Omega Fund Management as of March 31, 2024
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 11 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Nuvation Bio Common Stock Class A (NUVB) | 33.0 | $51M | 14M | 3.64 | |
| Lexeo Therapeutics Common Stock (LXEO) | 23.8 | $37M | 2.4M | 15.68 | |
| Replimune Group Common Stock (REPL) | 15.8 | $25M | 3.0M | 8.17 | |
| enGene Holdings Common Stock (ENGN) | 11.8 | $18M | 1.1M | 16.95 | |
| Sana Biotechnology Common Stock (SANA) | 5.4 | $8.4M | 844k | 10.00 | |
| Morphic Holding Common Stock (MORF) | 3.6 | $5.6M | 160k | 35.20 | |
| Ikena Oncology Common Stock (IKNA) | 2.1 | $3.2M | 2.2M | 1.42 | |
| Immunic Common Stock (IMUX) | 1.5 | $2.4M | 1.8M | 1.32 | |
| enGene Holdings Warrant (ENGNW) | 1.2 | $1.9M | 361k | 5.20 | |
| Syros Pharmaceuticals Common Stock (SYRS) | 0.9 | $1.3M | 251k | 5.35 | |
| Kronos Bio Common Stock (KRON) | 0.8 | $1.2M | 956k | 1.30 |
